GLP-Squared Oral
The GLP-Squared Oral Protocol from PlexusDx is a compounded dual-compound GLP-1 formulation combining Semaglutide and Tirzepatide as a daily oral tablet, prescribed by licensed providers as a clinical step-up. Starts at $369/mo on the 3-month plan — all-inclusive, covering async provider consultation, prescription, compounded medication, and shipping. Available in all 50 states (five states require a scheduled live consultation rather than async intake). No membership required. Your dose may need to go up. Your price won't. Your provider titrates your dose based on your clinical response; your monthly price is flat across every dose level for this compound. Two commitment tiers: $389 month-to-month and $369 on the 3-month plan. The optional Precision Peptide Genetic Test analyzes 34 Weight Management insights including GIPR rs1800437 — a variant associated with differential GLP-1 response — drawn from a 150+ insight panel across 14 pathways. Available for $99 as an add-on after your first month of treatment.
Variants (1)
- Default Title — 369.00 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.